Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
作者信息
Muss H, Bundy B N, DiSaia P J, Twiggs L B
出版信息
Cancer Treat Rep. 1986 Oct;70(10):1231-2.
PMID:3530450
Abstract
摘要
相似文献
1
Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.替尼泊苷治疗上皮性卵巢癌：妇科肿瘤学组的一项II期试验
Cancer Treat Rep. 1986 Oct;70(10):1231-2.
2
Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.替尼泊苷治疗子宫颈鳞状细胞癌：妇科肿瘤学组的一项II期试验
Cancer Treat Rep. 1987 Sep;71(9):873-4.
3
Teniposide in refractory ovarian cancer: a phase II study.替尼泊苷治疗难治性卵巢癌：一项II期研究。
Cancer Treat Rep. 1984 May;68(5):815-6.
4
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.替尼泊苷（VM - 26）用于晚期难治性卵巢癌患者：荷兰卵巢癌联合研究组的一项II期研究
Eur J Cancer Clin Oncol. 1987 Jul;23(7):997-8. doi: 10.1016/0277-5379(87)90348-8.
5
Phase II trial of VM-26 in patients with metastatic malignant melanoma.VM-26用于转移性恶性黑色素瘤患者的II期试验。
Cancer Treat Rep. 1978 Mar;62(3):445-7.
6
7
Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Cancer Treat Rep. 1986 Feb;70(2):307-8.
8
High-dose teniposide for refractory malignancies: a phase I study.高剂量替尼泊苷治疗难治性恶性肿瘤：一项I期研究。
Cancer Treat Rep. 1986 May;70(5):595-8.
9
10
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
Cancer Treat Rep. 1978 Jul;62(7):993-6.
Zotero 插件